Guggenheim Capital’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,274
| Closed | -$1.14M | – | 2165 |
|
|
2021
Q3 | $1.14M | Buy |
13,274
+505
| +4% | +$43.4K | 0.01% | 1348 |
|
|
2021
Q2 | $1.42M | Buy |
12,769
+440
| +4% | +$48.9K | 0.01% | 1287 |
|
|
2021
Q1 | $1.37M | Sell |
12,329
-514
| -4% | -$57.2K | 0.01% | 1225 |
|
|
2020
Q4 | $1.36M | Buy |
12,843
+1,831
| +17% | +$194K | 0.01% | 1168 |
|
|
2020
Q3 | $1.53M | Buy |
+11,012
| New | +$1.53M | 0.01% | 1006 |
|
|
2019
Q2 | – | Sell |
-48,168
| Closed | -$2.16M | – | 2141 |
|
|
2019
Q1 | $2.16M | Buy |
48,168
+32
| +0.1% | +$1.43K | 0.02% | 1031 |
|
|
2018
Q4 | $2.31M | Buy |
48,136
+6,068
| +14% | +$291K | 0.02% | 967 |
|
|
2018
Q3 | $2.81M | Buy |
42,068
+32
| +0.1% | +$2.14K | 0.02% | 1050 |
|
|
2018
Q2 | $1.98M | Sell |
42,036
-23
| -0.1% | -$1.08K | 0.01% | 1261 |
|
|
2018
Q1 | $2.38M | Buy |
+42,059
| New | +$2.38M | 0.01% | 1513 |
|
|
2015
Q1 | – | Sell |
-22,039
| Closed | -$2.43M | – | 3048 |
|
|
2014
Q4 | $2.43M | Buy |
22,039
+3,107
| +16% | +$342K | 0.01% | 1580 |
|
|
2014
Q3 | $2.24M | Buy |
+18,932
| New | +$2.24M | 0.01% | 1659 |
|
|
2014
Q1 | – | Sell |
-1,371
| Closed | -$191K | – | 3247 |
|
|
2013
Q4 | $191K | Buy |
1,371
+81
| +6% | +$11.3K | ﹤0.01% | 2797 |
|
|
2013
Q3 | $128K | Hold |
1,290
| – | – | ﹤0.01% | 2758 |
|
|
2013
Q2 | $49K | Buy |
+1,290
| New | +$49K | ﹤0.01% | 2824 |
|